APA aipamena

Kumano, Y., Hasegawa, Y., Kawahara, T., Yasui, M., Miyoshi, Y., Matsubara, N., & Uemura, H. (2019). Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide. Biomed Res Int.

Chicago Style aipamena

Kumano, Yohei, Yoriko Hasegawa, Takashi Kawahara, Masato Yasui, Yasuhide Miyoshi, Nobuaki Matsubara, and Hiroji Uemura. "Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide." Biomed Res Int 2019.

MLA aipamena

Kumano, Yohei, et al. "Pretreatment Neutrophil to Lymphocyte Ratio (NLR) Predicts Prognosis for Castration Resistant Prostate Cancer Patients Underwent Enzalutamide." Biomed Res Int 2019.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.